Spontaneous remission in acute myelogenous leukemia: a case report.
A 62-year-old woman with hypocellular acute myelogenous leukemia experienced spontaneous remission after repeated episodes of severe infections. Transient surge of profuse blasts in the peripheral blood was observed prior to the occurrence of spontaneous remission. The duration of the spontaneous remission was relatively short, and the disease relapsed five months later. A second complete remission was achieved after chemotherapy with low-dose cytosine arabinoside. The patient finally died of relapsed leukemia after a second remission of three year duration. Possible mechanisms implicated in the occurrence of spontaneous remission in this patient are discussed.
Gau
J P
JP
Department of Internal Medicine, Taichung Veterans General Hospital, Taiwan, R.O.C.
Young
J H
JH
Lin
T H
TH
Yang
Y
Y
Ho
K C
KC
D000964:Antimetabolites, Antineoplastic / Q000008:administration & dosage; D016913:Blood Component Transfusion / Q000009:adverse effects; D003561:Cytarabine / Q000008:administration & dosage; D005260:Female; D006086:Graft vs Host Disease / Q000209:etiology; D006801:Humans; D015470:Leukemia, Myeloid, Acute / Q000628:therapy; D008875:Middle Aged; D009364:Neoplasm Recurrence, Local; D009365:Neoplasm Regression, Spontaneous; D012074:Remission Induction
D000964:Antimetabolites, Antineoplastic; D003561:Cytarabine